Clinical Trial

Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2026 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-24.
Status change: Not Yet Recruiting → Recruiting 2026-03-14
Trial Details
NCT Number NCT07251712
Lead Sponsor Galmed Pharmaceuticals Ltd
Conditions Healthy
Enrollment 32 participants
Start Date 2025-12-25
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-17